logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
P

Peter M. Irving

guys and st thomas nhs foundation trust
H指数:74
被引数:1.9万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

The UK vedolizumab real-life experience study in inflammatory bowel disease (VEST): patient characteristics, drug persistence and patient-centred outcomes

英国 Vedolizumab 真实世界经验研究在炎症性肠病（VEST）：患者特征、药物持续性和以患者为中心的结局

Therapeutic Advances in Gastroenterology
IF3.4
2026-05-310
PRE
Keith Bodger; Cheryl Booker; Frederick Taylor; Tariq Ahmad; Stuart Bloom; Jeffrey Butterworth; ; Klaartje Kok; Alan Lobo; Peter Irving; J. R. Fraser Cummings
Comparative Efficacy and Safety of Advanced Therapies in Maintenance Treatment of Adult Patients with Moderate-to-Severe Crohn’s Disease: A Systematic Literature Review and Network Meta-Analysis

先进疗法在中重度克罗恩病成年患者维持治疗中的疗效和安全性比较: 系统文献回顾和网络荟萃分析

Advances in Therapy
IF4
2026-01-190
OAAI
Stefan Schreiber; Silvio Danese; Jean-Frédéric Colombel; Tadakazu Hisamatsu; Peter M. Irving; Hyunsoo Park; Dong-Hyeon Kim; Young Nam Lee; Stephen B. Hanauer
Safety and Efficacy of Ozanimod in Patients With Moderately to Severely Active Ulcerative Colitis Stratified by Age

奥扎尼妥（Ozanimod）在按年龄分层的中度至重度活动性溃疡性结肠炎患者中的安全性与有效性

INFLAMMATORY BOWEL DISEASES
IF4.3
2025-11-010
PRE
Faye, Adam S.; Rubin, David T.; Siegel, Corey A.; Long, Millie D.; Khan, Nabeel; Danese, Silvio; Irving, Peter M.; Cross, Raymond K.; Blumenstein, Irina; Armuzzi, Alessandro; Horst, Sara N.; Dignass, Axel; Kobayashi, Taku; Lawlor, Garrett; Krakovich, Anthony; Petersen, Annkatrin; Liu, Zhaohui; Wang, Dong; Jain, Anjali; Ananthakrishnan, Ashwin N.; Sabino, Joao
Design and rationale for the VICTRIVA study: A randomized, double-blind, phase 3b study of vedolizumab in combination with upadacitinib in Crohn's disease

VICTRIVA研究的设计与原理：一项关于vedolizumab与upadacitinib联合治疗克罗恩病的随机、双盲、3b期研究

CONTEMPORARY CLINICAL TRIALS COMMUNICATIONS
IF1.4
2025-11-010
OAAI
Danese, Silvio; Sands, Bruce E.; Feagan, Brian G.; Jairath, Vipul; Panaccione, Remo; Peyrin-Biroulet, Laurent; Irving, Peter M.; Schreiber, Stefan; Dotan, Iris; Ferrante, Marc; D'haens, Geert R.; Jones, Stephen; Freire, Marcelo; Lindner, Dirk; Adsul, Shashi; Oberai, Pooja; Colombel, Jean-Frederic
Mirikizumab Provides Sustained Long-Term Efficacy Up to 4 Years of Treatment for Ulcerative Colitis: Extended Induction Results From the LUCENT-3 Open-Label Study

Mirikizumab为溃疡性结肠炎患者提供长达4年的持续长期疗效：来自LUCENT-3开放标签研究的扩展诱导结果

AMERICAN JOURNAL OF GASTROENTEROLOGY
IF7.6
2025-10-010
PRE
Sands, Bruce E.; Clemow, David; D'Haens, Geert R.; Vermeire, Severine; Irving, Peter; Kobayashi, Taku; Peyrin-Biroulet, Laurent; Samaan, Karen; Gaur, Anil; Folian, Sarah; Arora, Ravneet; Paquette, Nicholas; Moses, Richard E.; Dignass, Axel
Long-Term Ozanimod Therapy in Patients With Moderately Active Ulcerative Colitis After Failure of 5-Aminosalicylic Acid

奥扎尼莫德长期治疗对5-氨基水杨酸治疗失败的轻中度溃疡性结肠炎患者的疗效

INFLAMMATORY BOWEL DISEASES
IF4.3
2025-09-010
OAAI
Yarur, Andres; Irving, Peter; Siegmund, Britta; Dubinsky, Marla C.; Ananthakrishnan, Ashwin N.; Regueiro, Miguel; Ungaro, Ryan C.; Ritter, Timothy; Nakase, Hiroshi; Liu, Zhaohui; Mehra, Dimpy; Osterman, Mark T.; Jain, Anjali; Rubin, David T.; Hibi, Toshifumi
Fecal loss of vedolizumab is associated with ulcerative colitis severity, lower serum vedolizumab levels, and rates of clinical response: results from the FAVOUR study

Samaan, M.A.; Cunningham, G.; Lim, S.H.; Dawson, P.; Kottoor, S.H.; Bheekhun, Z.; Lee, E.; Anderson, S.H.; Mawdsley, J.; Ray, S.; et al. 粪便中vedolizumab的流失与UC严重程度、血清vedolizumab水平降低以及临床应答率相关：FAVOUR研究的结果。J. Crohns Colitis 2025, 19, jjaf159. [Google Scholar] [CrossRef] [PubMed]

JOURNAL OF CROHNS & COLITIS
IF8.7
2025-09-011
PRE
Samaan, Mark A.; Cunningham, Georgina; Lim, Samuel Hsiang; Dawson, Patrick; Kottoor, Sherine Hermangild; Bheekhun, Zareen; Lee, Emma; Anderson, Simon H.; Mawdsley, Joel; Ray, Shuvra; Powell, Nick; Rawstron, Krystal; Dart, Robin; Zehra, Arkir; Irving, Peter M.
Assessment of PredictSURE IBD Assay in a Multinational Cohort of Patients With Inflammatory Bowel Disease

评估PredictSURE IBD检测在跨国炎症性肠病患者队列中的应用

United European Gastroenterology Journal
IF6.7
2025-07-110
OAAI
Dahham Alsoud; Nurulamin M. Noor; Lea Ann Chen; Vivian Abadom; Simon H. C. Anderson; Lediona Ardolli; Jordan Axelrad; Peter Bossuyt; Kenneth Croitoru; Oriana M. Damas; Lily Deng; Parakkal Deepak; Juan De La Revilla Negro; Shanika de Silva; Marc Ferrante; Karen Hills; Peter M. Irving; James O. Lindsay; Dana J. Lukin; Paul A. Lyons; Eoin F. McKinney; Maria Oliva-Hemker; Caterina Oneto; Roohi Patel; Miles Parkes; Lieven Pouillon; João Sabino; Lawrence J. Saubermann; Jenny S. Sauk; Sarah Sheibani; Kenneth G. C. Smith; Keith S. Sultan; Tony C. Tham; Sare Verstockt; Raluca Vrabie; Melissa Weidner; Huimin Yu; Bram Verstockt; James C. Lee; Séverine Vermeire
Anti-tumor Necrosis Factor Drug Concentration Is Not Associated with Disease Outcomes in Pouchitis: A Retrospective, International Study

抗肿瘤坏死因子药物浓度与储袋炎疾病结局无关：一项回顾性、国际性研究

DIGESTIVE DISEASES AND SCIENCES
IF2.5
2025-01-271
PRE
Honap, Sailish; Caron, Benedicte; Ollech, Jacob E.; Fischman, Maya; Papamichael, Konstantinos; De Jong, Djuna; Gecse, Krisztina B.; Centritto, Andrea; Samaan, Mark A.; Irving, Peter M.; Sparrow, Miles P.; Karmiris, Konstantinos; Chateau, Thomas; Dotan, Iris; Peyrin-Biroulet, Laurent; Int Consortium Therapeutic Drug Monitoring spECTRUM
A Randomized, Double-Blind, Placebo-Controlled Trial of Vedolizumab With and Without Upadacitinib in Adults With Crohn's Disease: Design and Rationale for the VICTRIVA Study
AMERICAN JOURNAL OF GASTROENTEROLOGY
IF7.6
2024-10-010
PRE
Danese, Silvio; Sands, Bruce E.; Feagan, Brian G.; Jairath, Vipul; Panaccione, Remo; Peyrin-Biroulet, Laurent; Irving, Peter M.; Schreiber, Stefan; Dotan, Iris; Ferrante, Marc; D'Haens, Geert R.; Jones, Stephen; Freire, Marcelo; Lindner, Dirk; Adsul, Shashi; Oberai, Pooja; Colombel, Jean-Frederic

研究方向

暂未获取到该数据
M
Miranda Lomer
H 指数:51论文数:282被引数:1.1万
K
Kevin Whelan
H 指数:73论文数:473被引数:2.1万
J
James O. Lindsay
H 指数:71论文数:445被引数:2.1万
M
Miles Parkes
H 指数:74论文数:388被引数:6.2万
M
Mark Samaan
H 指数:33论文数:198被引数:5,131
T
Tariq Ahmad
H 指数:64论文数:347被引数:3.0万
N
Nicholas A. Kennedy
H 指数:61论文数:429被引数:1.6万
C
Corey A. Siegel
H 指数:63论文数:573被引数:1.5万
G
Gil Melmed
H 指数:55论文数:668被引数:1.1万
A
Adam S. Cheifetz
H 指数:57论文数:397被引数:1.1万